pilocarpine has been researched along with Candida Infection in 2 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pilocarpine may have no protective effect on dental caries, periodontitis, or oral candidiasis in patients with pSS." | 7.91 | The effect of pilocarpine on dental caries in patients with primary Sjögren's syndrome: a database prospective cohort study. ( Chen, TH; Chen, YC; Hsu, CY; Hung, KC; Ko, CH; Lin, CY; Lin, MS; Lin, YS, 2019) |
| "Pilocarpine may have no protective effect on dental caries, periodontitis, or oral candidiasis in patients with pSS." | 3.91 | The effect of pilocarpine on dental caries in patients with primary Sjögren's syndrome: a database prospective cohort study. ( Chen, TH; Chen, YC; Hsu, CY; Hung, KC; Ko, CH; Lin, CY; Lin, MS; Lin, YS, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, CY | 1 |
| Hung, KC | 1 |
| Lin, MS | 1 |
| Ko, CH | 1 |
| Lin, YS | 1 |
| Chen, TH | 1 |
| Lin, CY | 1 |
| Chen, YC | 1 |
| Nile, C | 1 |
| Falleni, M | 1 |
| Cirasola, D | 1 |
| Alghamdi, A | 1 |
| Anderson, OF | 1 |
| Delaney, C | 1 |
| Ramage, G | 1 |
| Ottaviano, E | 1 |
| Tosi, D | 1 |
| Bulfamante, G | 1 |
| Morace, G | 1 |
| Borghi, E | 1 |
2 other studies available for pilocarpine and Candida Infection
| Article | Year |
|---|---|
The effect of pilocarpine on dental caries in patients with primary Sjögren's syndrome: a database prospective cohort study.
Topics: Adult; Candidiasis; Dental Caries; Female; Humans; Male; Middle Aged; Muscarinic Agonists; Outcome A | 2019 |
Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cholinergic Agonists; Disease Models, Ani | 2019 |